Company Active LTD

Company profile

52 North Health Ltd

Home | 52 North

We create affordable, cutting-edge technology to bring healthcare closer to patients.

CRN
11460425
Founded
2018
Age
7

Overview

Legal name
52 NORTH HEALTH LTD
Region
East Midlands
Registered address
KETTON SUITE THE KING CENTRE
MAIN ROAD
BARLEYTHORPE
OAKHAM
ENGLAND
LE15 7WD
Insolvency history
No

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
12

Company events

Reference milestones and recent Companies House filing stream events.

14 events
30 Sep
2027

Accounts due

Accounts Due

Next accounts due date

07 Mar
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

21 Feb
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2025

Accounts filed

Accounts

Last accounts made up date

25 Nov
2024

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzQ0NDc4NzMzM2FkaXF6a2N4

Published 25 Nov 2024 02:53

22 Nov
2024

Resolution

Resolution

RESOLUTIONS | Transaction WURGUDVXVlZhZGlxemtjeA | Paper/PDF filed

Published 23 Nov 2024 11:18

22 Nov
2024

Memorandum Articles

Incorporation

MA | Transaction MzQ0MjgxMDE4MmFkaXF6a2N4 | Paper/PDF filed

Published 23 Nov 2024 10:56

22 Nov
2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQ0NDU5NTc4M2FkaXF6a2N4

Published 22 Nov 2024 01:26

13 Nov
2024

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzQ0MjgwNzc3M2FkaXF6a2N4

Published 13 Nov 2024 10:44

13 Nov
2024

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzQ0MzAyMjMwMmFkaXF6a2N4

Published 13 Nov 2024 08:30

12 Nov
2024

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzQ0MjgwODE3OGFkaXF6a2N4

Published 12 Nov 2024 12:45

12 Nov
2024

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzQ0MjgwNzUzMGFkaXF6a2N4

Published 12 Nov 2024 12:39

12 Nov
2024

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzQ0MjgwNzQzN2FkaXF6a2N4

Published 12 Nov 2024 12:39

11 Jul
2018

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2020
Funded years
2020, 2022, 2023
Age at first award
1 years

Projects

2023 Collaborative R&D Lead participant

Development of the NeutroCheck diagnostic device to enable remote triage of chemotherapy patients at risk of neutropenic sepsis

1 Jan 2023 to 30 Sep 2024

Awarded
£680,317
Total cost £971,882

Neutropenic sepsis (NS) is a life-threatening complication of cancer chemotherapy. It occurs because chemotherapy temporarily suppresses the immune system, particularly neutrophil cells, and even mild illnesses can be fatal for patients during this time. As a result, if any chemotherapy patient has a fever or feels unwell they are advised to attend hospit...

2022 Knowledge Transfer Partnership

University of Cambridge and 52 North Health KTP 21-22 R4

1 Dec 2022 to 31 May 2025

Awarded
£0
Total cost £0

To synthesise new antibodies and develop new cutting-edge lateral flow-based diagnostics to support more precise monitoring of cancer patients at risk of complications from chemotherapy

2020 Study Lead participant

Development of the NeutroCheck medical device for use in chemotherapy patients at risk of neutropenic sepsis

1 Jan 2020 to 31 Dec 2020

Awarded
£94,500
Total cost £135,000

Neutropenic sepsis (NS) is a life-threatening medical emergency that occurs in patients having chemotherapy. NS occurs because chemotherapy may suppress the immune system and if patients develop an infection during this time, even a mild illness can be fatal. Delays to antibiotic use increase the risk of death. The key blood cell that is suppressed and le...

Product types

Collaborative R&D Knowledge Transfer Partnership Study